Literature DB >> 24277511

PET-CT in oncological patients: analysis of informal care costs in cost-benefit assessment.

Antonio Orlacchio1, Anna Micaela Ciarrapico, Orazio Schillaci, Fabrizio Chegai, Daniela Tosti, Fabrizio D'Alba, Manlio Guazzaroni, Giovanni Simonetti.   

Abstract

PURPOSE: The authors analysed the impact of nonmedical costs (travel, loss of productivity) in an economic analysis of PET-CT (positron-emission tomography-computed tomography) performed with standard contrast-enhanced CT protocols (CECT).
MATERIALS AND METHODS: From October to November 2009, a total of 100 patients referred to our institute were administered a questionnaire to evaluate the nonmedical costs of PET-CT. In addition, the medical costs (equipment maintenance and depreciation, consumables and staff) related to PET-CT performed with CECT and PET-CT with low-dose nonenhanced CT and separate CECT were also estimated.
RESULTS: The medical costs were 919.3 euro for PET-CT with separate CECT, and 801.3 euro for PET-CT with CECT. Therefore, savings of approximately 13% are possible. Moreover, savings in nonmedical costs can be achieved by reducing the number of hospital visits required by patients undergoing diagnostic imaging.
CONCLUSIONS: Nonmedical costs heavily affect patients' finances as well as having an indirect impact on national health expenditure. Our results show that PET-CT performed with standard dose CECT in a single session provides benefits in terms of both medical and nonmedical costs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24277511     DOI: 10.1007/s11547-013-0340-5

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  22 in total

1.  Estimated radiation risks potentially associated with full-body CT screening.

Authors:  David J Brenner; Carl D Elliston
Journal:  Radiology       Date:  2004-07-23       Impact factor: 11.105

2.  A retrospective evaluation of radiation dose associated with low dose FDG protocols in whole-body PET/CT.

Authors:  Kathy P Willowson; Elizabeth A Bailey; Dale L Bailey
Journal:  Australas Phys Eng Sci Med       Date:  2011-12-10       Impact factor: 1.430

Review 3.  Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance.

Authors:  R Edward Coleman; Dominique Delbeke; Milton J Guiberteau; Peter S Conti; Henry D Royal; Jeffrey C Weinreb; Barry A Siegel; Michael F Federle; David W Townsend; Lincoln L Berland
Journal:  J Nucl Med       Date:  2005-07       Impact factor: 10.057

Review 4.  Positron-emission tomography and assessment of cancer therapy.

Authors:  Malik E Juweid; Bruce D Cheson
Journal:  N Engl J Med       Date:  2006-02-02       Impact factor: 91.245

5.  PET/CT in cancer patient management. Introduction.

Authors:  Johannes Czernin; Heinrich R Schelbert
Journal:  J Nucl Med       Date:  2007-01       Impact factor: 10.057

6.  Low dose non-enhanced CT versus standard dose contrast-enhanced CT in combined PET/CT protocols for staging and therapy planning in non-small cell lung cancer.

Authors:  Anna C Pfannenberg; Philip Aschoff; Klaus Brechtel; Mark Müller; Roland Bares; Frank Paulsen; Jutta Scheiderbauer; Godehard Friedel; Claus D Claussen; Susanne M Eschmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-08-01       Impact factor: 9.236

7.  Value of contrast-enhanced multiphase CT in combined PET/CT protocols for oncological imaging.

Authors:  A C Pfannenberg; P Aschoff; K Brechtel; M Müller; M Klein; R Bares; C D Claussen; S M Eschmann
Journal:  Br J Radiol       Date:  2007-02-28       Impact factor: 3.039

8.  PET/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management.

Authors:  Zohar Keidar; Nissim Haim; Luda Guralnik; Mirjana Wollner; Rachel Bar-Shalom; Alon Ben-Nun; Ora Israel
Journal:  J Nucl Med       Date:  2004-10       Impact factor: 10.057

Review 9.  The role of FDG-PET scans in patients with lymphoma.

Authors:  Pamela Seam; Malik E Juweid; Bruce D Cheson
Journal:  Blood       Date:  2007-08-20       Impact factor: 22.113

10.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.

Authors:  Didier Lardinois; Walter Weder; Thomas F Hany; Ehab M Kamel; Stephan Korom; Burkhardt Seifert; Gustav K von Schulthess; Hans C Steinert
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

View more
  3 in total

1.  Usefulness of esophagogastroduodenoscopy and 18F-fluorodeoxyglucose positron-emission tomography in detecting synchronous multiple primary cancers with oral cancer.

Authors:  Naomi Ishibashi-Kanno; Kenji Yamagata; Fumihiko Uchida; Shogo Hasegawa; Toru Yanagawa; Hiroki Bukawa
Journal:  Oral Maxillofac Surg       Date:  2017-08-31

Review 2.  Combining Diagnostic Imaging and Pathology for Improving Diagnosis and Prognosis of Cancer.

Authors:  Orazio Schillaci; Manuel Scimeca; Nicola Toschi; Rita Bonfiglio; Nicoletta Urbano; Elena Bonanno
Journal:  Contrast Media Mol Imaging       Date:  2019-07-01       Impact factor: 3.161

Review 3.  Radiolabeled PET/MRI Nanoparticles for Tumor Imaging.

Authors:  Ernesto Forte; Dario Fiorenza; Enza Torino; Angela Costagliola di Polidoro; Carlo Cavaliere; Paolo A Netti; Marco Salvatore; Marco Aiello
Journal:  J Clin Med       Date:  2019-12-29       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.